Literature DB >> 25590004

Unexpectedly long intravenous and intracardiac extension of a small-sized pulmonary pleomorphic carcinoma.

Aya Ishii1, Tokuhiro Kimura1, Koshiro Moritani1, Dan Cui1, Shinsuke Tanaka1, Hiroo Kawano1, Eiji Ikeda1.   

Abstract

Pleomorphic carcinoma of the lung is one of the uncommon histological types of lung cancers, which shows an aggressive behavior. Intravenous extension (not metastasis or direct invasion) of the tumor into the heart is a rare complication of lung cancers. We present a case of a 64-year-old man, who was admitted to hospital due to severe dyspnea. Chest CT scan revealed a 2-cm nodule in the upper lobe of the right lung. Echocardiography demonstrated a giant mass in the left atrium. Because of a considerable distance between the lung nodule and heart, the relation of these two lesions was unclear. He died four days after the admission. At autopsy, the lung nodule was pleomorphic carcinoma composed of spindle and giant cells, which invaded the pulmonary vein and extended intravenously to the left atrium. The intravenous component of the tumor measured approximately ten cm in length. At the tip of the extension, an 8 cm × 5 cm × 3 cm mass was formed in the left atrium, which obstructed the mitral valve. This case highlights a possibility that even a small-sized, peripherally located pleomorphic carcinoma of the lung could extend for an unexpectedly long distance to the heart, causing cardiac complications.

Entities:  

Keywords:  Lung cancer; intracardiac extension; mitral valve; pleomorphic carcinoma; secondary cardiac tumor

Year:  2014        PMID: 25590004      PMCID: PMC4283330          DOI: 10.3978/j.issn.2072-1439.2014.10.25

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  14 in total

1.  Images in cardiology: Intra-left atrial invasive mass extended via the pulmonary vein.

Authors:  N Watanabe; K Kubo
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

2.  Intracardiac extension of a large cell undifferentiated carcinoma of lung.

Authors:  N Khan; J Golzar; N L Smith; A Movahed
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  Intracardiac extension of lung cancer via the pulmonary vein.

Authors:  M-T Lin; S-C Ku; M-Z Wu; C-J Yu
Journal:  Thorax       Date:  2008-12       Impact factor: 9.139

Review 4.  Tumors metastatic to the heart.

Authors:  Aaron D Goldberg; Ron Blankstein; Robert F Padera
Journal:  Circulation       Date:  2013-10-15       Impact factor: 29.690

Review 5.  Primary pulmonary sarcomatoid carcinoma with intracardiac extension.

Authors:  Siew-Weng Ng; Chong-Hee Lim; Ching-Wei Marian Wang; Yeow-Leng Chua
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-09

6.  Unusual extension of lung cancer into the left atrium via the pulmonary vein.

Authors:  K Kodama; O Doi; M Tatsuta
Journal:  Int Surg       Date:  1990 Jan-Mar

7.  Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.

Authors:  Giulio Rossi; Alberto Cavazza; Nathalie Sturm; Mario Migaldi; Nicola Facciolongo; Lucia Longo; Antonio Maiorana; Elisabeth Brambilla
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

8.  Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.

Authors:  Takahiro Mochizuki; Genichiro Ishii; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Tetsuya Mizuno; Tomoyuki Yokose; Kazuya Suzuki; Atsushi Ochiai
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

9.  Clinical characteristics of pleomorphic carcinoma of the lung.

Authors:  Kenichiro Ito; Satoshi Oizumi; Shinichi Fukumoto; Masao Harada; Takashi Ishida; Yuka Fujita; Toshiyuki Harada; Tetsuya Kojima; Hiroshi Yokouchi; Masaharu Nishimura
Journal:  Lung Cancer       Date:  2009-07-03       Impact factor: 5.705

10.  Intracardiac extension of a lung tumor causing left ventricular inflow obstruction.

Authors:  R R Brandt; J Rubin; G S Reeder
Journal:  J Am Soc Echocardiogr       Date:  1995 Nov-Dec       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.